Complete Report is available @ http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-india.html .
India is the second most populated country in the world with a population of approximately 1.22 billion in 2012, although the growth rate of the population is declining due to a decrease in the birth rate and an increase in net emigration. Unlike China and Japan, the working-age population accounts for the majority of the overall population. In order to derive maximum benefit, the government is currently working to develop human capital by increasing its spending on health and education. The country’s pharmaceutical market was estimated at $18.4 billion in 2012 and is expected to reach approximately $56 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 15%, primarily attributed to -
• Increasing coverage of healthcare insurance
• Improving access to healthcare facilities
• Government initiatives for the prevention and management of communicable diseases
India Pharmaceutical Industry to Grow at 3.7% CAGR to 2020
1. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – India
Single User PDF: US$ 1995
Corporate User PDF: US$ 5985
Order this report by calling
+1 888 391 5441 or Send an email
to sales@marketoptimizer.org
with your contact details and
questions if any.
1
2. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – India
India is the second most populated country in the world with a population of
approximately 1.22 billion in 2012, although the growth rate of the population is
declining due to a decrease in the birth rate and an increase in net emigration.
Unlike China and Japan, the working-age population accounts for the majority of
the overall population. In order to derive maximum benefit, the government is
currently working to develop human capital by increasing its spending on health
and education. The country’s pharmaceutical market was estimated at $18.4
billion in 2012 and is expected to reach approximately $56 billion by 2020 at a
Compound Annual Growth Rate (CAGR) of 15%, primarily attributed to –
Increasing coverage of healthcare insurance
Improving access to healthcare facilities
Government initiatives for the prevention and management of communicable
diseases
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
2
3. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – India
Researcher, the industry analysis specialist, has released its new report,
“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape India”.
The report is an essential source of information and analysis on India’s
healthcare, regulatory and reimbursement landscape. It identifies the key trends
in the healthcare market and provides insights into the demographic, regulatory
and reimbursement landscape and healthcare infrastructure. Most importantly,
it provides valuable insights into the trends and segmentation of the
pharmaceutical and medical device markets. The report is built using data and
information sourced from proprietary databases, secondary research and in-
house analysis by Researcher’s team of industry experts.
Inquiry before buying this Report @
http://www.marketoptimizer.org/contacts/inquire-before-
buying?rname=2814 .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
3
4. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – India
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
Develop business strategies by understanding the trends shaping and driving
India’s healthcare market.
Drive revenues by understanding the key trends, reimbursement and regulatory
policies, pharmaceutical market segments and companies likely to impact the
Indian healthcare market in the future.
Formulate effective sales and marketing strategies by understanding the
competitive landscape and analyzing the performance of various competitors.
Organize your sales and marketing efforts by identifying the market categories
and segments that present the most opportunities for consolidation, investment
and strategic partnership
Complete Report is available @
http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-
reimbursement-landscape-india.html .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
4
5. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – India
Scope
The report provides information on India’s healthcare, regulatory and
reimbursement landscape, and includes -
Overview of the pharmaceutical and medical devices markets, comprising
market size, segmentation and key drivers and barriers
Profiles and SWOT analysis of the major players in the pharmaceutical and
medical devices market. The major players covered for the pharmaceutical
market are Cipla, Sun Pharmaceuticals, Lupin, Ranbaxy Laboratories and Dr.
Reddy’s Laboratories. The major players covered for the medical devices market
are Siemens Healthcare, GE Healthcare, Essilor International, Johnson & Johnson
Vision Care and F. Hoffmann-La Roche.
Buy the copy of this Report @
http://www.marketoptimizer.org/contacts/purchase?rname=2814 .
Call Now + 1 888 391 5441 | Email at sales@marketoptimizer.org
5
6. CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape – India
About Us
marketoptimizer.org is an online market research reports library of 250,000+ in-depth
studies of over 5000 micro markets. Our database includes reports by leading publishers
from across the globe. We provide 24/7 online and offline support service to our
customers. marketoptimizer.org also offers company data, country profiles, trends,
information and analysis on the sector of your interest.
Visit Us @
http://www.marketoptimizer.org
Follow Us:
Call Now + 1 888 391 5441 | Email sales @ sales@marketoptimizer.org
6